Dutasteride for Androgenetic Alopecia: Review Article | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 163, Volume 90, Issue 1, January 2023, Page 1098-1101 PDF (411.53 K) | ||||
| DOI: 10.21608/ejhm.2023.280264 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Mohammed Youssef M. Alzaid 
| ||||
| Abstract | ||||
| Background: The disorder known as androgenetic alopecia (AGA), which is androgen-mediated, is characterised by a gradual loss of apparent scalp hair density. Dihydrotestosterone (DHT), which causes hair follicles to gradually shrink and thin out, targets genetically susceptible hair follicles. Hair loss, which typically starts at the hairline on both sides of the forehead, eventually causes the hair on top of the head to fall out. Dutasteride, a dual 5ARI, has been utilised in the clinic to treat AGA, demonstrating a unique mechanism and potent therapeutic impact. For patients with AGA, dutasteride could be an alternate therapy. Objective: This article aimed to highlights the dutasteride for androgenetic alopecia. Methods: PubMed, Google scholar and Science direct were searched using the following keywords: Dutasteride, Hair loss and Androgenetic alopecia. The authors also screened references from the relevant literature, including all the identified studies and reviews, only the most recent or complete studies were included. Conclusion: Dutasteride is now becoming popular treatment option in AGA, due to its good response for treatment Androgenetic alopecia. | ||||
| Keywords | ||||
| Dutasteride; Hair loss; Androgenetic alopecia | ||||
|
Statistics Article View: 798 PDF Download: 2,657 |
||||
